SPDR S&P Biotech ETF
123 hedge funds and large institutions have $1.05B invested in SPDR S&P Biotech ETF in 2013 Q2 according to their latest regulatory filings, with 123 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
123
Holders Change
+123
Holders Change %
–
% of All Funds
4.02%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
%
% of All Funds
0.13%
New
123
Increased
–
Reduced
–
Closed
–
Calls
$28.1M
Puts
$45.5M
Net Calls
-$17.4M
Net Calls Change
-$17.4M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$229M |
| 2 |
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$167M |
| 3 |
3
Goldman Sachs
New York
|
$110M |
| 4 |
4
Citigroup
New York
|
$89.6M |
| 5 |
5
Morgan Stanley
New York
|
$56.7M |
Top Sellers
No sellers this quarter
